ECE2016 Eposter Presentations Pituitary - Basic (17 abstracts)
1Institute for Clinical Chemistry, Laboratory Medicine and Transfusion Medicine, Paracelsus Medical University, Nuremberg, Germany; 2Georg Simon Ohm University, Nuremberg, Germany; 3Instituto de Química, Universidad Nacional Autónoma de México (UNAM), Delegacíon Coyoacan, México D.F., Mexico; 4Instituto de Neurobiología, Universidad Nacional Autónoma de México (UNAM), Campus UNAM-Juriquilla, Querétaro, Mexico.
Background: Full-length human prolactin (protein data bank identification P01236), the precursor of vasoinhibins, is structurally classified as a class-I helical cytokine with a four-helix bundle core and only a minimal degree of dark regions. Experimental data on the solution structure of vasoinhibins are not available.
Methods: A recombinant, human vasoinhibin with a molecular mass of 16.7 kDa, comprising amino acids 29-176 of prolactin, was expressed in E. coli and purified. Nuclear magnetic resonance (NMR) spectra were obtained (1D 1H, 2D TOCSY, 500/700 Mhz, and 2D NOESY, 950 Mhz). A homology modelling of the expected three-dimensional vasoinhibin structure, employing the I-TASSER web server, was performed. The purified vasoinhibin sample was subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western Blotting was performed using polyclonal and monoclonal, epitope-mapped anti-prolactin and anti-vasoinhibin antibodies.
Results: 1D NMR spectra at several conditions of pH, buffer and temperature demonstrated broad vasinhibin signals in a very narrow region with small differences between all spectra. Titration with trifluoroethanol and lithium chloride had minimal effect. TOCSY and NOESY experiments corroborated the results of all 1D experiments. Sodium dodecyl sulfate polyacrylamide gel electrophoresis and Western Blotting analyses demonstrated an anti-vasoinhibin antibody immunoreactive band with an apparent molecular mass of 16 kDa, consistent with the presence of the recombinant vasoinhibin-protein. Further immunoreactive bands of unknown identity with molecular masses of 28 and 35 kDa were detected.
Conclusion: Broad and little dispersion of few NH signals are interpreted as an unfolded vasoinhibin-protein in fast motion. Further NMR-studies are also complicated by possible aggregates of higher molecular masses. The homology model of the vasoinhibin structure did not correspond to NMR-data, and is thus considered unsuitable. The vasoinhibin structure hence retains a high degree of darkness.